CAS 68377-91-3: Arotinolol hydrochloride
Description:Arotinolol hydrochloride is a pharmaceutical compound primarily recognized for its role as a non-selective beta-adrenergic antagonist with additional alpha-adrenergic blocking properties. It is often utilized in the treatment of hypertension and certain cardiovascular conditions. The substance is characterized by its ability to lower blood pressure by inhibiting the effects of catecholamines on the heart and blood vessels, leading to decreased heart rate and vascular resistance. Arotinolol hydrochloride is typically administered in its hydrochloride salt form, which enhances its solubility and bioavailability. The compound is known to exhibit a moderate half-life, allowing for effective dosing regimens. In terms of safety and side effects, it may cause typical beta-blocker-related reactions, such as fatigue, dizziness, or bradycardia. As with many pharmaceuticals, its use should be monitored by healthcare professionals to manage potential interactions and contraindications effectively. Overall, Arotinolol hydrochloride represents a significant therapeutic option in the management of cardiovascular diseases.
Formula:C15H21N3O2S3·ClH
InChI:InChI=1S/C15H21N3O2S3.ClH/c1-15(2,3)17-6-9(19)7-21-14-18-10(8-22-14)11-4-5-12(23-11)13(16)20;/h4-5,8-9,17,19H,6-7H2,1-3H3,(H2,16,20);1H
InChI key:InChIKey=XXDAXBZYUXLDRD-UHFFFAOYSA-N
SMILES:Cl.O=C(N)C=1SC(=CC1)C=2N=C(SC2)SCC(O)CNC(C)(C)C
- Synonyms:
- 2-Thiophenecarboxamide, 5-[2-[[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-, hydrochloride (1:1)
- 2-Thiophenecarboxamide, 5-[2-[[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-, monohydrochloride
- 2-Thiophenecarboxamide, 5-[2-[[3-[(1,1-dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-, monohydrochloride, (S)-
- 5-(2-{[3-(Tert-Butylamino)-2-Hydroxypropyl]Sulfanyl}-1,3-Thiazol-4-Yl)Thiophene-2-Carboxamide
- Almarl
- Arotinolol Hcl
- S 596
- Arotinolol hydrochloride
